NCT03420963 2026-03-03Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid TumorsM.D. Anderson Cancer CenterPhase 1 Terminated12 enrolled
NCT02721459 2026-03-02XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1 Active not recruiting26 enrolled
NCT06870487 2026-02-19A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled
NCT04459273 2026-02-05FAPI PET RDRCJonsson Comprehensive Cancer CenterPhase 1 Active not recruiting26 enrolled
NCT05544929 2026-01-06A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNovartisPhase 1 Active not recruiting126 enrolled